Neoplasms such as anaplastic large-cell lymphoma, inflammatory myofibroblastic tumours, non-small-cell lung cancer (NSCLC), and neuroblastoma have rearrangements within the oncogenic ALK gene. This evidence concerns the gene ALK and neuroblastoma.